Zhang Lian Shan - Net Worth and Insider Trading

Zhang Lian Shan Net Worth

The estimated net worth of Zhang Lian Shan is at least $20 Million dollars as of 2024-06-24. Zhang Lian Shan is the Directors, senior managers of Jiangsu Hengrui Pharmaceuticals Co Ltd and owns about 497,152 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) stock worth over $20 Million. Details can be seen in Zhang Lian Shan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Zhang Lian Shan has not made any transactions after 2022-11-25 and currently still holds the listed stock(s).

Transaction Summary of Zhang Lian Shan

To

Zhang Lian Shan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zhang Lian Shan owns 1 companies in total, including Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) .

Click here to see the complete history of Zhang Lian Shan’s form 4 insider trades.

Insider Ownership Summary of Zhang Lian Shan

Ticker Comapny Transaction Date Type of Owner
SHSE:600276 Jiangsu Hengrui Pharmaceuticals Co Ltd 2022-11-25 Directors & senior managers

Zhang Lian Shan Latest Holdings Summary

Zhang Lian Shan currently owns a total of 1 stock. Zhang Lian Shan owns 497,152 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) as of November 25, 2022, with a value of $20 Million.

Latest Holdings of Zhang Lian Shan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600276 Jiangsu Hengrui Pharmaceuticals Co Ltd 2022-11-25 497,152 40.29 20,030,254

Holding Weightings of Zhang Lian Shan


Zhang Lian Shan Form 4 Trading Tracker

According to the SEC Form 4 filings, Zhang Lian Shan has made a total of 6 transactions in Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Jiangsu Hengrui Pharmaceuticals Co Ltd is the acquisition of 6,400 shares on November 25, 2022, which cost Zhang Lian Shan around $253,632.

Insider Trading History of Zhang Lian Shan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Zhang Lian Shan Trading Performance

GuruFocus tracks the stock performance after each of Zhang Lian Shan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Zhang Lian Shan is 8.98%. GuruFocus also compares Zhang Lian Shan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Zhang Lian Shan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Zhang Lian Shan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Zhang Lian Shan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.27 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.77 LIMIT LIMIT LIMIT LIMIT LIMIT

Zhang Lian Shan Ownership Network

Ownership Network List of Zhang Lian Shan

No Data

Ownership Network Relation of Zhang Lian Shan

Insider Network Chart

Zhang Lian Shan Owned Company Details

What does Jiangsu Hengrui Pharmaceuticals Co Ltd do?

Who are the key executives at Jiangsu Hengrui Pharmaceuticals Co Ltd?

Zhang Lian Shan is the Directors & senior managers of Jiangsu Hengrui Pharmaceuticals Co Ltd. Other key executives at Jiangsu Hengrui Pharmaceuticals Co Ltd include senior management Sun Xu Gen , senior management Yuan Kai Hong , and senior management Zou Jian Jun .

Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jiangsu Hengrui Pharmaceuticals Co Ltd Insider Transactions

No Available Data

Zhang Lian Shan Mailing Address

Above is the net worth, insider trading, and ownership report for Zhang Lian Shan. Currently GuruFocus does not have mailing address information for Zhang Lian Shan.

Discussions on Zhang Lian Shan

No discussions yet.